Cite
HARVARD Citation
Izumo, T. et al. (2016). Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment. BMC pulmonary medicine. 16 (1), pp. 1-6. [Online].